19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Getting SMARt in drug discovery: chemoinformatics approaches for mining structure–multiple activity relationships

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In light of the high relevance of polypharmacology, multi-target screening is a major trend in drug discovery.

          Abstract

          In light of the high relevance of polypharmacology, multi-target screening is a major trend in drug discovery. As such, the increasing amount of available structure–activity data requires the application of chemoinformatic approaches to mine structure–multiple activity relationships. To this end, activity landscape methods, initially developed to explore the structure–activity relationships for compounds screened against one target, have been adapted to mine Structure–Multiple Activity Relationships (SMARt). Herein, we survey advances in the chemoinformatic approaches to retrieve SMARt from screening data sets. Case studies relevant to modern drug discovery are discussed. The methods covered in this survey are general and can be implemented to explore the SMARt of other data sets screened across multiple biologically endpoints.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: not found
          • Article: not found

          On outliers and activity cliffs--why QSAR often disappoints.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Shifting from the single to the multitarget paradigm in drug discovery.

            Increasing evidence that several drug compounds exert their effects through interactions with multiple targets is boosting the development of research fields that challenge the data reductionism approach. In this article, we review and discuss the concepts of drug repurposing, polypharmacology, chemogenomics, phenotypic screening and high-throughput in vivo testing of mixture-based libraries in an integrated manner. These research fields offer alternatives to the current paradigm of drug discovery, from a one target-one drug model to a multiple-target approach. Furthermore, the goals of lead identification are being expanded accordingly to identify not only 'key' compounds that fit with a single-target 'lock', but also 'master key' compounds that favorably interact with multiple targets (i.e. operate a set of desired locks to gain access to the expected clinical effects). Copyright © 2013 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Exploring activity cliffs in medicinal chemistry.

                Bookmark

                Author and article information

                Journal
                RSCACL
                RSC Advances
                RSC Adv.
                Royal Society of Chemistry (RSC)
                2046-2069
                2017
                2017
                : 7
                : 2
                : 632-641
                Affiliations
                [1 ]Facultad de Química
                [2 ]Departamento de Farmacia
                [3 ]Universidad Nacional Autónoma de México
                [4 ]Avenida Universidad 3000
                [5 ]Mexico City 04510
                Article
                10.1039/C6RA26230A
                f2857349-3762-4d18-b548-7fd512859932
                © 2017
                History

                Comments

                Comment on this article